GRANTS

275 RESULTS

You searched notice-intent-publish-funding-opportunity-announcement-understanding-neurological-effects-0

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Treat FTD Fund

Sponsor: The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD)

Award: Up to $2,500,000 over 1 – 3 years, based on stage and scope of the trial.

Due Date: Letter of Intent due September 30th, 2024. Full Proposal due December 9th, 2024.

Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in MCI and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required) (RFA-NS-25-010)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: Direct Costs cannot exceed $6,700,000 per year. The maximum project period is 7 years. NIH intends to fund one award contingent upon NIH appropriations.

Due Date: LOI due December 24, 2024. Application due January 24, 2025.

Current Filters

  • Keyword: notice-intent-publish-funding-opportunity-announcement-understanding-neurological-effects-0 x

Remove all filters

Filter By